Companies/Invent Medic Sweden AB
Follow

Invent Medic Sweden AB

Spotlight Stock Market (Sweden)

Invent Medic focus on female health, where the company currently develops products for incontinence. The product is named TVS, and the vision is to improve quality of life for women with female-related health problems.
Go to market

Sector:
HEALTH CARE
>
Health Care Equipment & Services
Media
www.inventmedic.se
Current instruments
Type
Ticker
ISIN
SHARE
IMS
SE0007603402
Spotlight Stock Market Sweden (SE)
Top
News
BioStock: Invent Medics vd om vägen till positivt kassaflöde
22 Sep 2023 - 09:15
Kommuniké från extra bolagsstämma i Invent Medic Sweden AB (publ)
19 Sep 2023 - 16:20
BioStock Investor Pitch: Invent Medic
13 Sep 2023 - 08:15
Invent Medic offentliggör informationsmemorandum med anledning av förestående företrädesemission
11 Sep 2023 - 08:36
Kallelse till extra bolagsstämma i Invent Medic Sweden AB (publ)
31 Aug 2023 - 08:39
Styrelsen för Invent Medic beslutar om en företrädesemission om 5 MSEK
31 Aug 2023 - 08:27
BioStock: Invent Medic tecknar distributionsavtal i Australien
28 Aug 2023 - 08:15
BioStock: Invent Medic signs distribution agreement in Australia
28 Aug 2023 - 08:15
BioStock: Invent Medic fortsatt aktiva inom femtech-konsolidering framöver – vd
24 Aug 2023 - 09:45
BioStock: Invent Medic remains active in femtech consolidation going forward – CEO
24 Aug 2023 - 09:45
Invent Medic tecknar avtal för distribution av Efemia kontinensstöd i Australien med PFLEX Pty Ltd
24 Aug 2023 - 08:55
Invent Medics produkt Efemia kontinensstöd nu tillgänglig för förskrivning i Region Gävleborg
22 Aug 2023 - 08:55
Invent Medic publicerar delårsrapport för andra kvartalet 2023
17 Aug 2023 - 08:59
BioStock: Invent Medic utökar produktportföljen med menstrosa
30 Jun 2023 - 08:15
BioStock: Invent Medic expands product portfolio with period panties
30 Jun 2023 - 08:15
Invent Medic lanserar menstrosan Flow Undies
21 Jun 2023 - 14:00
BioStock: Invent Medic fortsätter expandera med nya ramavtal för Efemia Bladder Support
31 May 2023 - 08:45
BioStock: Invent Medic continues to expand with new framework agreement for Efemia Bladder Support
31 May 2023 - 08:45
Invent Medic tecknar ramavtal i fem nya regioner för Efemia kontinensstöd
24 May 2023 - 09:00
BioStock: Trefaldigad försäljning för hungrigt Invent Medic
19 May 2023 - 08:15
BioStock: Tripled sales for Invent Medic
19 May 2023 - 08:15
Kommuniké från årsstämma i Invent Medic Sweden AB (publ)
05 May 2023 - 15:31
Invent Medic publicerar delårsrapport för första kvartalet 2023
05 May 2023 - 09:02
Invent Medic publicerar Årsredovisning för 2022 och Beslutsunderlag inför årsstämma
14 Apr 2023 - 14:12
BioStock: Invent Medic går in i Frankrike
13 Apr 2023 - 08:15
BioStock: Invent Medic enters France
13 Apr 2023 - 08:15
BioStock: Positivt resultat i Invent Medics ryttarstudie
30 Mar 2023 - 09:15
BioStock: Positive result in Invent Medic’s equestrian study
30 Mar 2023 - 09:15
Invent Medic utser Bivea till distributör av Efemia Bladder Support i Frankrike
29 Mar 2023 - 09:00
Kallelse till årsstämma i Invent Medic Sweden AB (publ)
28 Mar 2023 - 13:00
Invent Medic publicerar positiva resultat från internationell ryttarstudie
27 Mar 2023 - 09:00
BioStock: Fortsatta försäljningsframgångar för Invent Medic
08 Mar 2023 - 09:15
BioStock: Continued sales success for Invent Medic
08 Mar 2023 - 09:15
Invent Medic lanserar Efemia Bladder Support på Island med distributören Stoð
02 Mar 2023 - 13:54
Invent Medic publicerar Bokslutskommuniké 2022 - Fortsatt stabil försäljningsökning och genomfört förvärv av FlowCup.
28 Feb 2023 - 08:36
Invent Medic sponsrar Svenska Fotbollförbundet och Svenska Spels menssatsning Alla dagar
24 Feb 2023 - 09:00
BioStock: Invent Medic satsar mot växande mensskyddsmarknad
22 Feb 2023 - 09:45
BioStock: Invent Medic invests in growing feminine care products market
22 Feb 2023 - 09:45
Invent Medic lanserar FlowCup Flex internationellt på flowcup.com
09 Feb 2023 - 11:30
Invent Medic meddelar utfall i riktade emissioner av teckningsoptioner
01 Feb 2023 - 18:00
1 2 3 4 5
Show

40

Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
IMS
SE0007603402
Spotlight Stock Market
Sweden (SE)
Details of share in Invent Medic Sweden AB with ticker IMS
Status
Active
Currency
SEK
First trading date
29 Feb 2016
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
IMS
SE0007603402
Spotlight Stock Market
Sweden (SE)
Details of share in Invent Medic Sweden AB with ticker IMS
Status
Active
Currency
SEK
First trading date
29 Feb 2016
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
IMS TO1
SE0013720042
Spotlight Stock Market
Sweden (SE)
Details of option in Invent Medic Sweden AB with ticker IMS TO1
Status
Archived
Currency
SEK
Trading period
01 Apr 2020 - 16 Mar 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for SEK 6.75 during the period February 25, 2021 - March 18, 2021.
Update (12.03.2021): Last day for warrants TO1 trading is March 16, 2021.
Exercise
Sign in to buy
People
Anna Lindström
CEO
Gun-Britt Fransson
Chairman of the board
Frida Wilhelmsson Ulfbratt
Board member
Helen Richenzhagen
Board member
Helena Liljedahl
Board member
Lars Persson
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Medicon Village
Zip code
223 81
City/district
Lund
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
556682-1046
LEI code
549300QOP1K65X8KC141
First trade date
29 Feb 2016
Registration date
20 Jun 2005
Short name
IMS

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More